FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

69711000001105: Neoclarityn 5mg tablets (Organon Pharma (UK) Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1733001000001117 Neoclarityn 5mg tablets (Organon Pharma (UK) Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1733021000001112 Neoclarityn 5mg tablets (Organon Pharma (UK) Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Neoclarityn 5mg tablets (Organon Pharma (UK) Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Neoclarityn 5mg tablets (Organon Pharma (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Neoclarityn 5mg tablets (Organon Pharma (UK) Ltd) Is a Product containing precisely desloratadine 5 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Neoclarityn 5mg tablets (Organon Pharma (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Neoclarityn 5mg tablets (Organon Pharma (UK) Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Neoclarityn 5mg tablets (Organon Pharma (UK) Ltd) Has active ingredient Desloratadine false Inferred relationship Existential restriction modifier
Neoclarityn 5mg tablets (Organon Pharma (UK) Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Neoclarityn 5mg tablets (Organon Pharma (UK) Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Neoclarityn 5mg tablets (Organon Pharma (UK) Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Neoclarityn 5mg tablets (Organon Pharma (UK) Ltd) Is a Neoclarityn true Inferred relationship Existential restriction modifier
Neoclarityn 5mg tablets (Organon Pharma (UK) Ltd) Has specific active ingredient Desloratadine true Inferred relationship Existential restriction modifier
Neoclarityn 5mg tablets (Organon Pharma (UK) Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Neoclarityn 5mg tablets (Organon Pharma (UK) Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Neoclarityn 5mg tablets (Organon Pharma (UK) Ltd) 30 tablet 3 x 10 tablets Is pack of False Neoclarityn 5mg tablets (Organon Pharma (UK) Ltd) Inferred relationship Existential restriction modifier
Neoclarityn 5mg tablets (Organon Pharma (UK) Ltd) 30 tablet 3 x 10 tablets Has AMP True Neoclarityn 5mg tablets (Organon Pharma (UK) Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start